From October 1, 2022 to December 30, 2022, the company has repurchased 866,200 shares, representing 0.53% for CNY 19.07 million. With this, the company has completed the repurchase of 2,389,050 shares, representing 1.44% for CNY 50.02 million under the buyback announced on April 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.98 CNY | -1.24% | -16.98% | -17.15% |
23/05 | Hvsen Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024 | CI |
25/04 | Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.15% | 270M | |
-14.09% | 77.37B | |
+18.66% | 8.74B | |
+23.75% | 3.67B | |
-0.42% | 3.25B | |
+18.07% | 1.73B | |
-16.99% | 1.38B | |
-26.05% | 1.24B | |
-17.86% | 1.07B | |
-6.77% | 976M |
- Stock Market
- Equities
- 300871 Stock
- News Hvsen Biotechnology Co., Ltd.
- Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.